SPPL2A and Alzheimer disease: Another novel candidate AD risk gene that we nominate in this study, SPPL2A, encodes a transmembrane aspartyl protease that localizes to late endosomes and lysosomes and cleaves substrates involved in immunity and neurodegeneration61–63.